The Forum for Collaborative Research Supports Second Annual International NASH Day on June 12, 2019
Washington DC, June 12, 2019 – The Forum for Collaborative Research announced its recognition of International NASH Day (IND). Over 30 organizations are coming together today to raise awareness for NASH and promote early intervention of this disease, which affects more than 115 million people worldwide.
Read more »
|
Liver Forum Publication Addresses Endpoints for Nonalcoholic Steatohepatitis Trials
Washington DC, May 23, 2019 – The Forum for Collaborative Research announced publication of a new article, "Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations from the Liver Forum," in the peer-reviewed journal, HEPATOLOGY.
Read more »
Press Release: Forum for Collaborative Research Publishes Principles for Trials of Combination Therapies in Patients with Chronic Viral Hepatitis B
Washington DC, March 22, 2019 – The Forum for Collaborative Research announced the publication of a manuscript, "Challenges, Considerations, and Principles to Guide Trials of Combination Therapies for Chronic Hepatitis B Virus" in the February 2019 volume of the peer-reviewed journal Gastroenterology.
Read more »
Press Release: Liver Forum Publication on Baseline Parameters in NASH Clinical Trials
Washington DC, November 8, 2017 – The Liver Forum is pleased to announce the publication of its first manuscript, Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum,published as a Commentary in the September 2017 volume of the peer-reviewed journal Gastroenterology. The development of this manuscript included input and contributions from key opinion leaders in the field of NASH, and was led by Dr. Yuval Patel (Duke University), Dr. Andrew Muir (Duke University), and Dr. Joanne Imperial (Conatus Pharmaceuticals). The published article is available at: https://doi.org/10.1053/j.gastro.2017.07.024.
Read more »
Press Release: The Forum Launches New Project Focused on Developing Treatment for the Rare Disease PSC
Washington D.C., June 19, 2017- The Forum for Collaborative Research is launching the PSC Forum to advance the regulatory science for the development of therapeutics for PSC and its associated morbidities.
Read more »
Press Release: The Forum Celebrates 20 Years
The Forum for Collaborative Research formerly The Forum for Collaborative HIV Research
We, the Forum for Collaborative Research, affiliated with the University of California Berkeley School of Public Health, are celebrating our twentieth anniversary this year. This milestone comes with changes as a result of the Forum’s achievements, and recommendations from our Executive Committee members. For the past two decades, the Forum’s work with HIV has evolved into a disease-specific model for multi-stakeholder collaboration that now addresses other disease areas including liver diseases (non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and primary sclerosing cholangitis), viral hepatitis (B and C), cytomegalovirus, among others. Thus, the Forum for Collaborative Research will now be comprised of different disease-specific Forums including:
- The CMV Forum
- The HBV Forum
- The HCV Forum
- The HIV Forum
- The Liver Forum
Read more »
PRESS RELEASE: First Public Meeting of Cross-Sector HIV Cure Project Convenes June 17th in Washington, DC
On June 13-14, at a time when dozens of research trials are challenging the long-held assumption that HIV is incurable, the Forum for Collaborative HIV Research is convening the first public meeting of the Forum HIV Cure Project: Focus on Regulatory Issues, a multi-stakeholder project that involves expert working groups and engagement with the broader HIV community to address emerging scientific and regulatory hurdles in HIV cure research. Click here to read the full press release.
Forum Applauds Task Force Call for Testing All Baby Boomers for the Hepatitis C Virus
JUN-25-13 In response to the decision by the U.S. Preventive
Services Task Force (USPSTF) to expand coverage requirements for the one-time
testing of all baby boomers (born from 1945-1965) for the hepatitis C virus (HCV), Veronica Miller, PhD, Executive Director of
the Forum for Collaborative HIV Research, issued this statement on behalf of
the leaders in HIV/AIDS and viral hepatitis from government,
academia, industry and the patient advocacy community that comprise the
organization.
Read more »
Press Release - Experts Propose New Terminology for Hepatitis C Drug Trials
DEC-18-12 Outdated terminology has made it difficult to assess the clinical
benefits of next-generation direct-acting antiviral drugs and
combination therapies now in the pipeline. A new paper from the Forum
for Collaborative HIV Research recommends the adoption of a standardized
nomenclature that will bring simplicity and clarity to the field, allow
for inter-trial comparisons and can be adapted to continuing advances
in hepatitis C virus (HCV) drug development.
Read more »
Press Release - National Summit on HIV and Viral Hepatitis Convenes Nov. 26-28 in Washington
NOV-21-12 At a time when the prevalence of HIV among some Americans rivals
parts of sub-Saharan Africa and recorded deaths from chronic hepatitis C
infection are steadily increasing, the Forum for Collaborative
HIV Research will convene its 2012
National Summit on HIV and Viral Hepatitis Diagnosis, Prevention and Access to
Care to intensify the nation's prevention, detection and treatment efforts.
Read more »
Press Release - Major Gaps in Access to Care Are Impeding Progress in Reducing HIV/AIDS
AUG-15-12 As global leaders assembled in
Washington for the XIX International AIDS Conference, a special
gathering of researchers, government officials and HIV/AIDS advocates
confronted the new reality of the epidemic in the U.S. – a dramatic
increase in HIV among men who have sex with men (MSM), minority
populations, the poor and the disenfranchised living in discreet
geographic regions, especially in urban areas of the Northeast and West
Coast and cities and small towns in the South.
Read more »
|
|